Suppr超能文献

TRα1受体的药理学抑制增强了甲状腺素对大鼠体重减轻的作用:对控制体重的潜在治疗意义。

Pharmacological inhibition of TRalpha1 receptor potentiates the thyroxine effect on body weight reduction in rats: potential therapeutic implications in controlling body weight.

作者信息

Pantos C, Mourouzis I, Paizis I, Malliopoulou V, Xinaris Ch, Moraitis P, Cokkinos A D, Cokkinos D V

出版信息

Diabetes Obes Metab. 2007 Jan;9(1):136-8. doi: 10.1111/j.1463-1326.2006.00587.x.

Abstract

It has been previously reported that thyroid hormone receptor alpha1 (TRalpha1) is involved in the regulation of food intake and heart rhythm. Herein, we show that pharmacological inhibition of TRalpha1 by dronedarone, an amiodarone like compound (shown to antagonize thyroid hormone binding to TRalpha1), prevented the thyroid hormone induced increase in food intake and heart rate acceleration in rats. This resulted in a marked reduction in body weight. It is likely that thyroid analogs may prove potential therapeutic agents for controlling body weight.

摘要

先前已有报道称,甲状腺激素受体α1(TRα1)参与食物摄入和心律的调节。在此,我们表明,决奈达隆(一种类似胺碘酮的化合物,已证明可拮抗甲状腺激素与TRα1的结合)对TRα1的药理抑制作用,可防止甲状腺激素诱导的大鼠食物摄入量增加和心率加快。这导致体重显著下降。甲状腺类似物可能被证明是控制体重的潜在治疗药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验